American Journal of Psychiatry

Papers
(The median citation count of American Journal of Psychiatry is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Broadening the Parameters of Clinical High Risk for Psychosis446
2024 Annual Meeting: Presidential Address360
Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma190
A New Agenda for Optimizing Investments in Community Mental Health and Reducing Disparities172
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?133
Evaluating Associations Between Cannabis and Heroin Use132
Treating Pathologies of the Will121
Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia120
Mental Health Disparities Research: An Introduction to New Directions116
Highlights From the Residents’ Journal: December 2021109
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosi106
A Call to Psychiatrists: Deprescription of Unnecessary Anticholinergic Medications in Schizophrenia Must Start Now106
Cannabis and Brain Health: What Is Next for Developmental Cohort Studies?99
Neural Signatures of Pain Modulation in Short-Term and Long-Term Mindfulness Training: A Randomized Active-Control Trial92
Can Neuromelanin-Sensitive MRI Provide Insight Into the Dopaminergic Pathways Contributing to Substance Use?90
Project Harmony: A Meta-Analysis With Individual Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic Stress and Alcohol or Other Drug Use Disorders90
Depression, Inflammation, and Postpartum Psychosis88
From Prediction to Action: Moving Beyond Machine Learning to Implementing Evidence-Based Perinatal Mental Health Care88
On the Genetic and Environmental Relationship Between Suicide Attempt and Death by Suicide84
20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis84
Intentional Drug Overdose Deaths in the United States84
Genes To Mental Health (G2MH): A Framework to Map the Combined Effects of Rare and Common Variants on Dimensions of Cognition and Psychopathology80
Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia79
An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression78
New Insights Into Psychotic Disorders78
2024 Annual Meeting: CEO and Medical Director’s Address76
Correcting Overestimations in Self-Harm Visit Data75
Highlights From the Residents’ Journal: September 202175
APA Council Reports69
Older Adults are at Heightened Risk of the Effects of Cannabis Use: Response to Walaszek69
Highlights From the Residents’ Journal: September 202469
Correction to Poirot et al.65
Neural Responses to Intranasal Oxytocin in Youths With Severe Irritability64
Corrigendum to Morley et al.64
Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.62
Suicide and the Menstrual Cycle59
Similar Rates of Deleterious Copy Number Variants in Early-Onset Psychosis and Autism Spectrum Disorder58
Whole Brain White Matter Tract Deviation and Idiosyncrasy From Normative Development in Autism and ADHD and Unaffected Siblings Link With Dimensions of Psychopathology and Cognition57
Coordinate Network Mapping: An Emerging Approach for Morphometric Meta-Analysis56
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials54
Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression54
12-month Prevalence Estimates of Substance Use Disorders Using DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use54
Early Adversity and Development: Parsing Heterogeneity and Identifying Pathways of Risk and Resilience53
Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden52
Familial Risk of Postpartum Psychosis51
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression51
The First Large GWAS Meta-Analysis for Postpartum Depression50
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial50
Trends in Prescription Stimulant, Opioid, and Benzodiazepine Use and Diversion in U.S. Adolescents50
Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population49
Risk of Incident Psychosis and Mania With Prescription Amphetamines48
Genetic and Environmental Contribution to the Co-Occurrence of Endocrine-Metabolic Disorders and Depression: A Nationwide Swedish Study of Siblings48
Aberrant Developmental Patterns of Gamma-Band Response and Long-Range Communication Disruption in Youths With 22q11.2 Deletion Syndrome47
The Neglected Role of Psychotherapy for Treatment-Resistant Depression47
Sexual Identity Continuity and Change in a U.S. National Probability Sample of Sexual Minority Adults: Associations With Mental Health and Problematic Substance Use46
Associations Between a Primary Care-Delivered Alcohol-Related Brief Intervention and Subsequent Opioid-Related Outcomes45
Points that Need Attention in Early Auditory Information Processing Research in Schizophrenia: Response to Lin and Hsieh44
Proof-of-Principle Study on ECT Illustrates Challenges and Possible Merits of Using Polygenic Risk Scores to Predict Treatment Response in Psychiatry43
Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities42
Rebecca W. Brendel, M.D., J.D., 149th President, 2022–202342
Predictive Value of Acute Neuroplastic Response to rTMS in Treatment Outcome in Depression: A Concurrent TMS-fMRI Trial40
The Safety of Pimavanserin for Parkinson’s Disease and Efforts to Reduce Antipsychotics for People With Dementia40
Shared and Specific Neural Correlates of Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder: A Meta-Analysis of 243 Task-Based Functional MRI Studies40
Comment on “Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank”40
Sustained Efficacy of Stanford Neuromodulation Therapy (SNT) in Open-Label Repeated Treatment39
2021 Articles of Import and Impact38
Alcohol and the Etiology of Depression38
Slowly Working Toward More Treatments for Depression in Bipolar II Disorder37
Reduction in Trauma-Related Symptoms After Anesthetic-Induced Intra-Operative Dreaming37
Synaptic Variability and Cortical Gamma Oscillation Power in Schizophrenia37
Suicide in Black Females37
Psilocybin: From Psychiatric Pariah to Perceived Panacea36
What Do Four Decades of Research Tell Us About the Association Between Childhood Adversity and Psychosis: An Updated and Extended Multi-Level Meta-Analysis36
Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary35
Modification of Heritability for Educational Attainment and Fluid Intelligence by Socioeconomic Deprivation in the UK Biobank35
Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain35
Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial34
Evaluating the Machine Learning Literature: A Primer and User’s Guide for Psychiatrists33
Double-Blind, Sham-Controlled Randomized Trial Testing the Efficacy of fMRI Neurofeedback on Clinical and Cognitive Measures in Children With ADHD33
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder33
Neural Correlates of Stress and Alcohol Cue-Induced Alcohol Craving and of Future Heavy Drinking: Evidence of Sex Differences32
Predicting Acute Changes in Suicidal Ideation and Planning: A Longitudinal Study of Symptom Mediators and the Role of the Menstrual Cycle in Female Psychiatric Outpatients With Suicidality32
Cigarette Smoking and Heavy Alcohol Drinking: The Challenges and Opportunities for Combination Treatments32
Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment32
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression31
Can Smartphone-Based Support Apps Add Value to the Treatment of Opioid Use Disorder?31
The Association of Childhood Maltreatment and Mental Health Problems: Partly Causal and Partly Due to Other Factors31
Neuromodulation Strategies for the Treatment of Depression31
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders31
Changing the Face of Schizophrenia31
Drug Cues Trigger Corticolimbic Hyperreactivity in Heroin Users30
Psychiatric Diagnoses in Parents and Psychiatric, Behavioral, and Psychosocial Outcomes in Their Offspring: A Swedish Population-Based Register Study30
Correction to Baum et al.30
Keeping Track and Providing Tools for Future Crisis Management: Suicide Attempt and Self-Harm Presentations at Emergency Departments30
Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD29
Setting the Record Straight on Long-Term Use, Dose Escalation, and Potential Misuse of Prescription Benzodiazepines29
Harnessing the Power of Population Cohorts to Study the Relationship Between Endocrine-Metabolic Disorders and Depression29
Interindividual Differences in Cortical Thickness and Their Genomic Underpinnings in Autism Spectrum Disorder28
Structural Racism as a Proximal Cause for Race-Related Differences in Psychiatric Disorders28
Mortality Among Parkinson’s Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare Beneficiaries27
Racial and Ethnic Biases and Psychiatric Misdiagnoses: Toward More Equitable Diagnosis and Treatment27
A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability27
Differences in Social Determinants of Health Underlie Racial/Ethnic Disparities in Psychological Health and Well-Being: Study of 11,143 Older Adults27
Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary27
A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial26
Innovative Directions to Advance Mental Health Disparities Research26
Toward Precision Noninvasive Brain Stimulation26
Evaluating the Evidence for Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma26
Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review26
The Amygdala and Depression: A Sober Reconsideration26
2024 Articles of Import and Impact25
Correction25
Ketamine After Two Antidepressants?25
Auditory Steady-State Responses Probe GABA-Related Oscillatory Cortical Circuits and Their Relation to Neurodevelopmental Mental Disorders25
Guilt by Association: Inflammation and Shared Genetic Risk Between Stress-Related and Immune Disorders25
Highlights From the Residents’ Journal: December 202424
Understanding the Effects of Combined Lisdexamfetamine and Cognitive Behavior Therapy for Adults With Binge Eating Disorder24
Recommendations for the Usage of Ketamine and Esketamine24
Current and Future Approaches to Pediatric Anxiety Disorder Treatment24
Neuromelanin-Sensitive MRI: A Biomarker for Treatment-Resistant Schizophrenia?24
Converging Evidence for Frontopolar Cortex as a Target for Neuromodulation in Addiction Treatment23
Progress and Challenges in GxE Research on Depression23
Drugs and Addiction Science: NIDA Celebrates 50 Years of Research and Looks to the Future23
Associations Between General and Specific Mental Health Conditions in Young Adulthood and Cardiometabolic Complications in Middle Adulthood: A 40-Year Longitudinal Familial Coaggregation Study of 672,23
Ketamine and Esketamine for Treatment-Resistant Depression: Response to Reus, Mattes, and Schatzberg23
Functional Connectivity Mapping for rTMS Target Selection in Depression22
Cannabis Use and the Endocannabinoid System: A Clinical Perspective22
Longitudinal Trajectory of the Link Between Ventral Striatum and Depression in Adolescence22
Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy22
Time Course of Relapse Following Acute Treatment for Anorexia Nervosa22
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial22
Technology and Mental Health: State of the Art for Assessment and Treatment21
Late-Life Depression, Antidepressant Treatment, and Cognition: The Short Haul and the Long Haul21
Reports to the Membership21
Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features21
Behavior as Physiology: How Dynamical-Systems Theory Could Advance Psychiatry21
Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression21
Vaccines as Immunotherapies for Substance Use Disorders20
Can Two 90-Minute Workshops Reduce Risk of Substance Use Disorder for Vulnerable Seventh Graders? Results and Scalability From the Co-Venture Trial20
Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research20
Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?20
Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction20
Antidepressants and Bipolar Disorder: The Plot Thickens20
Perinatal Mental Health: Advances and Opportunities19
Recapitulation of Perturbed Striatal Gene Expression Dynamics of Donors’ Brains With Ventral Forebrain Organoids Derived From the Same Individuals With Schizophrenia19
Polygenic Risk Scores and Genetics in Psychiatry19
Anticholinergic Medication Burden–Associated Cognitive Impairment in Schizophrenia19
Psychotropic Drug–Related Weight Gain and Its Treatment19
Prevalence and Penetrance of Rare Pathogenic Variants in Neurodevelopmental Psychiatric Genes in a Health Care System Population19
Pathogenic Variants and Ascertainment: Neuropsychiatric Disease Risk in a Health System Cohort18
Putting Genetics to Work in the Psychiatric Clinic18
Varenicline as a First-Line Treatment for Individuals With Current Major Depressive Disorder Who Smoke Cigarettes18
Highlights From the Residents’ Journal: September 202318
An Insula-Enriched Regulator of Retinoic Acid Marks a New Intersection in the Neural Circuitry of Mouse Social Behavior18
Neglect of Adverse Effects in Treatment Guidelines for Depression18
Focusing on Substance Use Disorders, Opioids, and Craving18
Effects of County-Level Opioid Dispensing Rates on Individual-Level Patterns of Prescription Opioid and Heroin Consumption: Evidence From National U.S. Data17
Improved Response Inhibition Through Cognition-Guided EEG Neurofeedback in Men With Methamphetamine Use Disorder17
Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment17
Understanding the Value and Limitations of MRI Neuroimaging in Psychiatry17
The Risk of Overdose With Concomitant Use of Z-Drugs and Prescription Opioids: A Population-Based Cohort Study17
Intermittent Theta Burst Stimulation With Adjunctive D-Cycloserine for Obsessive-Compulsive Disorder: A Randomized Clinical Trial17
Neuropsychiatric Symptoms of Subacute and Chronic Long COVID17
Estimating Multimodal Structural Brain Variability in Schizophrenia Spectrum Disorders: A Worldwide ENIGMA Study17
Clozapine’s High Incidence of Ileus and Pneumonia Demand Better Clinical Strategies—How Do We Get There?17
Disclosure of Editors’ Financial Relationships16
Increased Inflammation in Depression: A Little in All, or a Lot in a Few?16
Reports to the Membership16
The Devastating Clinical Consequences of Child Abuse and Neglect: Increased Disease Vulnerability and Poor Treatment Response in Mood Disorders16
Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder16
Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia16
MORE Is Less Pain and Less Opioid Misuse: A Mindful Remedy15
Xanomeline-Trospium Treatment of Cognitive Impairments of Schizophrenia: Hope for Some, or Hope for All?15
Prospective Associations Between Structural Brain Development and Onset of Depressive Disorder During Adolescence and Emerging Adulthood15
MDMA and MDMA-Assisted Therapy15
New Insights Into Major Depression and the Treatment of Bipolar Depression15
Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis15
Psychosis Risk With Prescription Amphetamine15
Beyond the Landmarks: Where to Next With Biomarkers of Autism?15
Affective Disorders, Pharmacogenomics, and Psychiatric Illness-Related Cardiometabolic Problems15
Clozapine, Long-Acting Injectables (and Polypharmacy?) Superior in U.S. and International Registries15
The Intergenerational Impact of Structural Racism and Cumulative Trauma on Depression14
Intergenerational Effects of the Fast Track Intervention on Next-Generation Child Outcomes: A Preregistered Randomized Clinical Trial14
The Importance and Limitations of Null Findings14
Seeking New Solutions Addressing Structural Racism, Childhood Trauma, Suicidal Behaviors Across Sexual Orientations, and Postpartum Depression14
Treating Depression With Repetitive Transcranial Magnetic Stimulation: A Clinician’s Guide14
Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark14
What is the Link Between Substance-Induced Psychosis and Primary Psychotic Disorders?14
Highlights From the Residents’ Journal: June 202514
An Honest Reckoning With the Amygdala and Mental Illness14
Association Between Polygenic Risk Scores and Outcome of ECT14
Disclosure of Editors’ Financial Relationships14
20 Years of Aberrant Salience in Psychosis: What Have We Learned?13
Mechanism-Focused Randomized Controlled Trials in Youths: Another Step Uphill13
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis13
Drug Overdose Prevention: An Exercise in Optimism13
Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders13
Inequalities in the Incidence of Psychotic Disorders Among Racial and Ethnic Groups13
Can Cognitive-Behavioral Therapy Normalize Neural Function in Youths With Pediatric Anxiety Disorders? A Developmental Neuroscience Perspective13
Clarifying Confounder Variables and Cross-Sectional Power to Make Causal Conclusions About Race, Adversity, and Brain Differences: Response to Scheeringa12
The Conundrum of Treatment Discontinuation of Stimulant Medication for ADHD Despite Its Efficacy12
Psychopathology in Youth: Treatment, Parenting, and Intergenerational Transmission12
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial12
Grip Strength as a Marker of Resting-State Network Integrity and Well-Being in Early Psychosis12
Prevalence of Suicidal Ideation and Suicide Attempts by Race and Gender in Three Large U.S. Adolescent Cohorts12
Contraception, Intrauterine Systems, and Depression: Can We Spot the Real Perpetrator?11
Understanding and Addressing Widening Racial Inequalities in Drug Overdose11
Ketamine, the First Associative Anesthetic? Some Considerations on Classifying Psychedelics, Entactogens, and Dissociatives11
2021 Annual Meeting: President-Elect Address11
Cortical and Subcortical Brain Alterations in Specific Phobia and Its Animal and Blood-Injection-Injury Subtypes: A Mega-Analysis From the ENIGMA Anxiety Working Group11
Perspectives From the National Institutes of Health on Multidimensional Mental Health Disparities Research: A Framework for Advancing the Field11
Correction to Lebois et al.11
Evaluation of Antipsychotic Reduction Efforts in Patients With Dementia in Veterans Health Administration Nursing Homes11
The Psychiatric Bed Crisis in the United States: Understanding the Problem and Moving Toward Solutions11
Psychotherapy’s Role for Treatment-Resistant Depression: Reply to Bartova et al.10
Science Into Policy for the Benefit of Children: The Bucharest Early Intervention Project10
Neuroscientific Advances Supporting New Treatments for Major Depression10
Cell Type–Specific Profiles and Developmental Trajectories of Transcriptomes in Primate Prefrontal Layer 3 Pyramidal Neurons: Implications for Schizophrenia10
Using Principles of Trauma-Informed Care to Address Structural Racism in Psychiatric Care9
Correction to Guintivano et al.9
Infant Visual Brain Development and Inherited Genetic Liability in Autism9
Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic9
In Search of Biomarkers to Guide Interventions in Autism Spectrum Disorder: A Systematic Review9
Predicting Conversion to Psychosis Using Machine Learning: Are We There Yet?9
Suicide in Black Females: Response to Mattes9
Transforming Discoveries About Cortical Microcircuits and Gamma Oscillations Into New Treatments for Cognitive Deficits in Schizophrenia9
Polygenic Risk and Social Support in Predicting Depression Under Stress9
High Burden of Ileus and Pneumonia in Clozapine-Treated Individuals With Schizophrenia: A Finnish 25-Year Follow-Up Register Study9
Correction to Mattes9
Sex-Differential Neuroanatomy in Autism: A Shift Toward Male-Characteristic Brain Structure9
The Genetic Architecture of Obsessive-Compulsive Disorder: Contribution of Liability to OCD From Alleles Across the Frequency Spectrum9
Cerebrovascular Disease and Neuropsychiatric Disorders: Translating Findings From the MRI Scanner to the Clinic9
Entactogen Effects of Ketamine: A Reverse-Translational Study9
Charting the Landscape of Genetic Overlap Between Mental Disorders and Related Traits Beyond Genetic Correlation8
More Than Social Stigma Meets the Eye: The Inherent Struggle of Sexual and Gender Identity Development Across the Lifespan8
Telemental Health Care for Children and Adolescents in the United States: Challenges and Opportunities8
ADHD and ASD: Time to Split or Lump?8
Five-Year Outcomes of a School-Based Personality-Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial8
Genetic Underpinnings of the Transition From Alcohol Consumption to Alcohol Use Disorder: Shared and Unique Genetic Architectures in a Cross-Ancestry Sample8
Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III)8
Racial and Ethnic Bias in the Diagnosis of Alcohol Use Disorder in Veterans8
Structural Racism and the Imperative to Eliminate Mental Health Disparities8
Lack of Representation in Psychiatric Research: A Data-Driven Example From Scientific Articles Published in 2019 and 2020 in the American Journal of Psychiatry8
Reducing Duration of Untreated Psychosis: The Neglected Dimension of Early Intervention Services8
Correcting Overestimations in Self-Harm Visit Data: Response From Bommersbach and Colleagues8
Association of Cannabis Use–Related Predictor Variables and Self-Reported Psychotic Disorders: U.S. Adults, 2001–2002 and 2012–20138
Maternal Perinatal Stress Trajectories and Negative Affect and Amygdala Development in Offspring7
Treatments for Depression in Bipolar II Disorder7
Opioid Use Disorder: Pernicious and Persistent7
Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study7
0.11591792106628